The impact of platelet activation and inflammatory response on the onset of DVT implies that the inhibition of platelet aggregation, the down-regulation of the expression of P-selectin and GPIIb/IIIa, the decrease of serum levels of IL-2, IL-6 and IL-8 can benefit the prophylaxis of DVT. Here, IL6 is linked to deep vein thrombosis.